Navigation Links
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
Date:8/3/2009

reated patients (P < 0.0001). During the double-blind phase of the study, fewer patients treated with INVEGA(R) SUSTENNA(TM) experienced a relapse (10% [n=15/156]) compared with those in the placebo group (34% [n=53/156]).

Because maintenance of efficacy was demonstrated, the trial was ended early. Patients on INVEGA(R) SUSTENNA(TM) experienced a significant delay in time to relapse compared to placebo. Patients on placebo had a 3.6 fold higher incidence of experiencing relapse versus INVEGA(R) SUSTENNA(TM). As such, INVEGA(R) SUSTENNA(TM) has the potential to be of tremendous benefit for physicians, caregivers and patients.

In clinical trials, the most common adverse events (incidence greater than or equal to 5% and occurring at least twice as often as placebo) were injection site reactions, somnolence/sedation, dizziness, akathisia and extrapyramidal disorder.

"INVEGA(R) SUSTENNA(TM) provides healthcare professionals the opportunity to rethink their overall approach to how they treat schizophrenia by using long-acting therapies," said Husseini Manji, M.D., F.R.C.P.C., Global Therapeutic Area Head, Neuroscience, Johnson & Johnson Pharmaceutical Research & Development. "The approval of INVEGA(R) SUSTENNA(TM) demonstrates our commitment to providing valuable novel therapies for schizophrenia. INVEGA(R) SUSTENNA(TM) has a demonstrated safety profile that can help healthcare professionals address the issue of medication adherence and can also help many patients delay the time to relapse."

Visit http://www.INVEGASUSTENNA.com for full prescribing information.

IMPORTANT SAFETY INFORMATION FOR INVEGA((R)) SUSTENNA(TM)

INVEGA((R)) SUSTENNA(TM) is not approved for the treatment of dementia-related psychosis in elderly patients. Elderly
'/>"/>

SOURCE Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Video: New Dove(R) Body Washes with NutriumMoisture(TM) Restore Skins Natural Moisture
2. Video: Phase III Study Data With Vandetanib (Zactima(TM)) in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) Presented at American Society of Clinical Oncology
3. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
4. Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
5. Video: Partnership Unites UCB with Consumer Product Innovator OXO(R)
6. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
7. Video: Afinitor(R) Approved in US as First Treatment for Patients With Advanced Kidney Cancer After Failure of Either Sunitinib or Sorafenib
8. Video: Provectus PV-10 Interim Phase 2 Safety and Efficacy Results are as Good as or Better than Phase 1 Results
9. Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports
10. Video: Femara(R) First Aromatase Inhibitor to Indicate Survival Benefit Versus Tamoxifen When Taken for Five Years After Breast Cancer Surgery
11. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... YORK , March 31, 2015 Immune ... announced today that it intends to expand its planned ... human monoclonal antibody targeting eotaxin-1. Bullous Pemphigoid is an ... 60,000 patients in the US and Europe ... to start enrolling patients in a Phase II clinical ...
(Date:3/31/2015)... 2015 ANI Pharmaceuticals, Inc. ("ANI") (NASDAQ: ... 150mg, 225mg and 300mg oral tablets, indicated for use ... market for Propafenone Hydrochloride 150mg, 225mg and 300mg tablets ... Arthur S. Przybyl , President and Chief ... launch of our fourth product from the portfolio of ...
(Date:3/31/2015)... 2015   Unique Pharmaceuticals , a 503B outsourcing ... the company has initiated sterile compounding operations meeting the ... a company is to meet and exceed industry standards," ... the new regulations is validation of our quality management ... of our industry, investing in its continued success and ...
Breaking Medicine Technology:Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 2ANI Pharmaceuticals Announces the Launch of Propafenone Tablets 3Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 2Unique Pharmaceuticals Launches Sterile Operations under New Federal Guidance 3
(Date:3/31/2015)... Dr. St. Ledger recently returned from yet another trip ... Here, he participated in the Worn Dentition Workshop: a ... in cases of severely worn teeth, as well as the ... correlation to GERD and Sleep Apnea. , Dr. ... After the workshop he attended, he mentored for three days ...
(Date:3/31/2015)... Dr. Uzma Parvez is having a busy start ... Grand Grounds Presentations at St. Michael’s Medical Center for attending ... The event was attended by a large gathering of ... feedback from the Grand Rounds. It was said that ... a while. , Ahead, Dr. Parvez has been invited ...
(Date:3/31/2015)... OR (PRWEB) March 31, 2015 Former 49ers ... announcement than during his first year of a promising NFL ... Sports on Earth Senior Writer Will Leitch explores ... the league. Leitch talks about the decision making process that ... the preservation of health over a large paycheck, and what ...
(Date:3/31/2015)... March 31, 2015 Greenfield Senior ... Investment Trust LLC ("Care") a seniors housing-focused real ... Inc. Care announces today, their acquisition of six ... for $54.48 million. Concurrent with the acquisition, Care ... Greenfield Senior Living ("Greenfield"). Pursuant to the lease, ...
(Date:3/31/2015)... Nashville, TN (PRWEB) March 31, 2015 ... 16 countries have united to express their shared support ... living. Part of a 'True Health Coalition' and ... has been formed to help demonstrate that, despite appearances ... among diverse experts worldwide about the theme of healthful ...
Breaking Medicine News(10 mins):Health News:The dentists at Upper Montclair Dental Associates are happy to announce exciting new happenings at their practice. 2Health News:NJ Top Docs Presents, Dr. Uzma Parvez of Total Pain Care 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 2Health News:Will Leitch and the Curious Case of Chris Borland on SCI TV 3Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 2Health News:Greenfield Senior Living Inc. Enters Lease Transaction with Care Investment Trust LLC 3Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 2Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 3Health News:GLiMMER Initiative Founder David Katz, MD Announces the Launch of the True Health Coalition: Worldwide Experts Convened to Defend Fundamentals of Healthy Eating/Living 4
... very few public,health crises that can truly be cured ... one of them. There are 4.7 million people bitten ... mortality is,completely unnecessary., The American Veterinary Medical Association ... and the American Academy of Pediatrics,(AAP) in sponsoring Dog ...
... injured, so prevention strategies are key , , THURSDAY, May ... of falling after they leave the hospital, a New ... that prevention programs may help lower that risk. , "People ... as people who haven,t had a stroke. Falls are very ...
... is providing,free telephone interpretation services to anyone needing urgent ... in the,aftermath of Monday,s earthquake. The company,s British directors,currently ... support by,providing a language link for those most affected., ... 805 8503 from outside,China and 4006 88 66 99 ...
... appearing in the,May issue of Psychological Science, a ... being put in a low-power role may,impair a ... to,get ahead., In their article, Pamela Smith ... of VU University Amsterdam, Adam Galinsky of,the Kellogg ...
... Drugs for Health ... Seen Primarily in Adults, FRANKLIN LAKES, N.J., May 15 ... part by lifestyle,factors are rapidly afflicting children and leading to ... ills., New research released today by Medco Health Solutions, ...
... shingles cases, expert says , , THURSDAY, May 15 ... should be vaccinated against shingles, a condition that can ... Control and Prevention recommended on Thursday. , This new ... after the ZOSTAVAX vaccine was approved by the U.S. ...
Cached Medicine News:Health News:Veterinarians, Pediatricians and Postal Workers Team Up to Reduce Incidence of Dog Bites 2Health News:Stroke Patients at High Risk for Falls 2Health News:Having Less Power Impairs the Mind and Ability to Get Ahead, Study Shows 2Health News:Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children 2Health News:Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children 3Health News:Kids Growing Up on Grown Up Drugs: New Research Shows Treatments for Adult Ailments Rapidly Rising in Children 4Health News:CDC Recommends Shingles Vaccine for Those Over 60 2Health News:CDC Recommends Shingles Vaccine for Those Over 60 3
The Cordis ANGIOGUARD Capture Guidewire is the first embolic protection device shown in clinical testing to achieve a relative stroke reduction of 70% during carotid stenting procedures....
... point-of-care device for the qualitative detection of drug ... TOX/See device can detect up to nine of ... 8 minutes and requires only a few drops ... to maximize convenience and ease of use. TOX/See ...
... TOX/See™ is a 1-step, hand-held, point-of-care device ... metabolites in human urine. The TOX/See device ... commonly abused drugs in 3 to 8 minutes ... Each TOX/See cassette is individually packaged to maximize ...
... is a 1-step, hand-held, point-of-care device for the ... human urine. The TOX/See device can detect ... drugs in 3 to 8 minutes and requires ... cassette is individually packaged to maximize convenience and ...
Medicine Products: